Mergers & Acquisitions Law and Finance Fourth Edition [Including Connected Ebook] (Aspen Casebook) Series 4th Robert B. Thompson cover
Aspen Casebook Casebook Series

Casebooks · Fourth Edition

Mergers & Acquisitions Law and Finance Fourth Edition [Including Connected Ebook] (Aspen Casebook) Series 4th Robert B. Thompson

ISBN
9781543847512
Publisher
Aspen Publishing
Edition
Fourth Edition
$94.28 one-time purchase · 15% restocking fee on returns

Shipping calculated at checkout

Secure checkout

Condition guaranteed or your money back

Product details

Description

Buy a new version of this textbook and receive access to the Connected eBook on CasebookConnect, including: lifetime access to the online ebook with highlight, annotation, and search capabilities, plus an outline tool and other helpful resources. Connected eBooks provide what you need most to be successful in your law school classes.
The Fourth Edition of Mergers & Acquisitions: Law and Finance, written by Robert B. Thompson, a leading scholar and teacher in the field, equips students with the legal rules and economic and financial principles they will need to help clients make key strategic choices during an acquisition. Mergers & Acquisitions: Law and Finance offers up-to-date and rich, yet succinct, coverage with the perfect mix of theory and practice.
New to the Fourth Edition: The 2021 anti-activist poison pill case (In re The Williams Company) Linking the introduction to tender offers in Chapter 3 as an anomaly to Delaware’s preferred approach to trust governance to directors setting the stage for Chapter 5 and the judicial acceptance of poison pills to address that anomaly Revising the presentation of Blasius as initially providing a necessary supplement to Unocal, but evolving into a rule that is “rarely” applied Akorn as illustrating the Delaware Chancery Court’s increasing case load of complex commercial cases in takeovers (as opposed to governance fights between shareholders and directors)
Professors and students will benefit from: Stellar authorship Rich but accessible coverage of valuation Notes following each case that explain the legal and business reasoning for “The Deal” Materials on insider trading, poison pill, deal protection devices, activist shareholders